How Has the Comprehensive Metabolic Panel (CMP) Testing Market Size Evolved in Recent Years?
The comprehensive metabolic panel (cmp) testing market has seen considerable growth due to a variety of factors.
•In recent years, the market size of the comprehensive metabolic panel (CMP) testing has seen robust growth. Projected to rise from $17.04 billion in 2024 to $18.39 billion in 2025, it's expected to exhibit a compound annual growth rate (CAGR) of 7.9%.
Factors contributing to this growth during the historical period include an increase in chronic diseases, the desire for comprehensive health evaluations, the healthcare system's focus on preventive care, a surge in conditions related to lifestyle, and a patient-focused healthcare approach.
What are the Market Size and Expected Growth Rates for the Comprehensive Metabolic Panel (CMP) Testing Market?
The comprehensive metabolic panel (cmp) testing market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, substantial expansion is anticipated in the comprehensive metabolic panel (CMP) testing market, with a projection of reaching $26.02 billion by 2029, following a compound annual growth rate (CAGR) of 9.1%.
Factors contributing to this predicted surge include the shift towards personalized and precision healthcare, the inclusion of CMP testing within telehealth services, an increased call for comprehensive health assessments, enhanced focus on wellness and preventive health strategies, and progressive healthcare policies and regulations. The forecast period is also likely to observe several trends such as ongoing monitoring and longitudinal tracking, telehealth compatible report formats, unified reference range standards, the adoption of wearable health technology, and stress on patient awareness and involvement.
Which Key Drivers Are Propelling The Comprehensive Metabolic Panel (CMP) Testing Market's Growth?
The rise in cardiovascular disorders and diabetes is projected to stimulate the expansion of the comprehensive metabolic panel (CMP) testing market. Heart and blood vessel-related problems, tied to atherosclerosis - a condition characterized by fatty build-up in the arteries, are categorized as cardiovascular diseases. High blood sugar levels can lead to diabetes. The CMP blood tests are utilized to measure glucose levels, hence the escalating instances of diabetes and heart diseases make these tests crucial for their diagnosis, fueling the market growth. For example, the Australian Institute of Health and Welfare reported 13,700 doctor-certified deaths due to CHD in 2020, rising to 14,100 in 2021 and 14,900 in 2022, by December 2023. In another instance, the International Diabetes Federation reported in June 2022, that the global prevalence of diabetes had grown to 10.5%, with 44.7% of affected individuals remaining undiagnosed. It is this increasing occurrence of heart diseases and diabetes that is spurring the expansion of the comprehensive metabolic panel (CMP) testing market.
What Are The Key Segments Within The Global Comprehensive Metabolic Panel (CMP) Testing Market?
The comprehensive metabolic panel (CMP) testing market covered in this report is segmented –
1) By Disease: Kidney Disease, Liver Disease, Diabetes, Other Diseases
2) By Test Type: Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose
3) By End User: Laboratories, Point Of Care (PoC)
Subsegments:
1) By Kidney Disease: Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), Glomerulonephritis
2) By Liver Disease: Hepatitis (Viral And Non-Viral), Cirrhosis, Fatty Liver Disease
3) By Diabetes: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
4) By Other Diseases: Cardiovascular Diseases, Electrolyte Imbalances, Metabolic Disorders, Pancreatic Diseases
Pre-Book The Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Comprehensive Metabolic Panel (CMP) Testing Market?
The emergence of cutting-edge technologies is a principal trend gaining traction in the comprehensive metabolic panel (CMP) testing market. Dominant companies in the CMP testing market are creating novel technologies to maintain their market standing. For instance, in April 2022, HealthifyMe, a wellness and fitness service corporation based in India, rolled out HealthifyPro, a primary fitness regimen. The metabolic panel for the HealthifyPro scheme is predicated on a blood test capable of assessing over 80 diverse elements. Prominent components incorporated into HealthifyPro to monitor users' health encompass a biosensor framework (BIOS), an intelligent scale, health mentors, HealthifyMe's artificial intelligence assistant, and a metabolic panel. This arrangement amalgamates glucose pattern data with user's dietary intake and varied exercise habits to fashion a custom plan for each user.
Who Are the Key Players in the Comprehensive Metabolic Panel (CMP) Testing Market?
Major companies operating in the comprehensive metabolic panel (CMP) testing market include:
• Abbott Laboratories Inc.
• Siemens Healthineers AG
• Mayo Clinic
• Laboratory Corporation of America Holdings
• Mercy
• Mount Sinai Health System
• Quest Diagnostics Incorporated
• Sonic Healthcare Limited
• Hologic Inc.
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Werfen SA
• DiaSorin S.p.A.
• Randox Laboratories Ltd.
• ARUP Laboratories Inc.
• Invitae Corporation
• Abaxis Inc.
• Metropolis Healthcare Limited
• Clinical Reference Laboratory (CRL)
• Centogene AG
• Spectra Laboratories
• Unipath Systems Ltd.
• Scion Lab Services LLC
• Weldon Biotech Pvt Ltd.
• Corona Pathology
•Ulta Lab Tests LLC
• Any Lab Test Now
• Applied InGENuity Diagnostics LLC
• Walk-In Lab LLC
What are the Regional Insights into the Comprehensive Metabolic Panel (CMP) Testing Market?
North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (CMP) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
